source
- FDA clears Dexcom's Stelo as first OTC continuous glucose monitor for childrenThe U.S. Food and Drug Administration cleared Dexcom's Stelo Glucose Biosensor System for over-the-counter use in children two years of age and older who do not use insulin. This is the first OTC…
- Rapport Therapeutics says it is ready to launch its seizure drug independentlyIn a recent interview, CEO Abe Ceesay explained that Rapport Therapeutics has assembled an investor syndicate and feels fully prepared to bring its seizure drug to market on its own. Founded in 20…